VEXIM Initiates New Clinical Study of SpineJack vs. Conservative Treatment of VCFs

By Julie A. Vetalice

Vexim initiated a prospective, multi-center, randomized clinical study in France to compare safety, efficacy and cost-effectiveness at 1-year and 2-year follow-up of SpineJack® vs. bracing on 100 acute traumatic vertebral compression fracture patients.

The 4-site study is intended to reinforce existing clinical data and results of SpineJack in the treatment of osteoporotic and traumatic vertebral fractures, and joins an ongoing comparative study of SpineJack vs. Medtronic's KyphX Xpander® Inflatable Bone Tamp.

Source: Vexim

Tags: Trial/Study